Table 3.
Compd. No | MWa | LogPb | Log Sc | QPlog HERGd | QPP caco2e | Log BBf | Metabg | QPLog Khsah | % HOAi |
---|---|---|---|---|---|---|---|---|---|
1 | 453.56 | 5.18 | − 3.90 | − 5.69 | 591.32 | − 0.16 | 6 | 0.83 | 93.95 |
2 | 483.58 | 5.96 | − 6.25 | − 7.59 | 760.69 | − 0.26 | 7 | 1.03 | 100 |
3 | 362.49 | 4.35 | − 5.49 | − 7.58 | 401.76 | − 0.13 | 4 | 0.76 | 100 |
4 | 449.03 | 5.06 | − 3.73 | − 8.30 | 287.78 | 0.54 | 6 | 0.94 | 87.64 |
5 | 397.44 | 5.34 | − 5.57 | − 7.05 | 1267.41 | 0.70 | 6 | 0.85 | 100 |
6 | 391.37 | 4.57 | − 5.60 | − 7.03 | 746.09 | 0.66 | 4 | 0.60 | 100 |
7 | 453.56 | 4.77 | − 3.58 | − 6.41 | 685.05 | − 0.18 | 5 | 0.61 | 100 |
8 | 373.38 | 3.88 | − 4.46 | − 6.58 | 524.52 | 0.43 | 4 | 0.41 | 100 |
9 | 414.51 | 3.61 | − 4.30 | − 5.93 | 194.37 | − 0.31 | 3 | 0.47 | 89.06 |
10 | 451.56 | 5.43 | − 4.82 | − 6.42 | 682.53 | − 0.28 | 7 | 0.97 | 96.48 |
11 | 407.51 | 4.59 | − 4.54 | − 7.04 | 716.06 | − 0.09 | 6 | 0.68 | 100 |
12 | 484.04 | 6.13 | − 6.27 | − 7.25 | 918.95 | − 0.07 | 7 | 1.14 | 100 |
13 | 470.01 | 5.63 | − 4.56 | − 6.12 | 1244.17 | 0.23 | 5 | 0.80 | 100 |
14 | 407.48 | 5.41 | − 5.51 | − 7.90 | 959.10 | 0.14 | 3 | 0.91 | 100 |
15 | 469.56 | 5.21 | − 4.48 | − 6.20 | 713.70 | − 0.16 | 7 | 0.82 | 95.57 |
16 | 416.49 | 6.73 | − 8.63 | − 7.49 | 3518.97 | − 0.27 | 6 | 1.41 | 100 |
17 | 467.58 | 5.18 | − 5.38 | − 6.81 | 872.36 | − 0.13 | 6 | 1.06 | 100 |
Standard value | < 500 | 2.0–6.5 | > − 4 | > − 5 | < 25 (poor) and > 500 (excellent) | – | 1–8 | – 1.5 to 1.5 | 0–100% |
aMW: Molecular weight; (Da); bOil/water partition coefficient; cSolubility; dIC50 value for blockage of HERG K+ channels; eGut–blood barrier in nm/s permeability of the cell model; fBrain/blood partition coefficient; gNumber of metabolic reactions; hBinding to human serum albumin; iHuman oral absorption. The reference values for ADMET have been taken from the Ref [58]